General Info

MediQuest Therapeutics is a specialty biopharmaceutical company that focuses on the discovery and commercialization of products for the treatment of inflammatory and infectious diseases. It specializes in the development of actinic keratosis, ulcers, plaque psoriasis, excessive hair growth and skin infections. The company utilizes the Topical AmphiMatrix drug delivery technology, which develop therapies with various features, such as rapid local delivery, improved efficacy and reduced side effects for respective indications. It is involved in a variety of therapeutic categories, including peripheral vascular disorders, opportunistic infections, cutaneous and subcutaneous inflammatory diseases. MediQuest Therapeutics also deals in the prevention and treatment of Raynaud s. It additionally conducts epidemiology studies.